Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis
ConclusionDabrafenib + trametinib, pembrolizumab, and nivolumab were associated with higher ORR and prolonged PFS and OS compared with chemotherapy in previously treated advanced or metastatic NSCLC.FundingNovartis Pharmaceuticals Corporation.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Alimta | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Lung Cancer | Non-Small Cell Lung Cancer | Study | Tarceva | Taxotere